Boston Scientific Announces Results for Second Quarter 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Boston Scientific (BSX) PT Raised to $32 at Cowen
July 27, 2017 3:50 PM EDTCowen raised its price target on Boston Scientific (NYSE: BSX) to $32.00 (from $31.00) while maintaining a Outperform rating.
Management revised full year 2017 guidance and effectively kept the midpoint of the organic revenue guidance range intact at 5.8% while raising the EPS target by $0.01.
... MoreStifel Reiterates Buy on Boston Scientific (BSX) Following 2Q
July 27, 2017 1:41 PM EDTStifel reiterated a Buy rating and $32.00 price target on Boston Scientific (NYSE: BSX) following the company's 2Q. Revenue at $2.257 billion grew 6% reported and on organic basis, and 7% on an operational basis. BSX modestly raised the top-end of its previous 2017 organic sales growth... More
